Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 201–300 of 1,007
Protein post-translational modifications in the regulation of cancer hallmarks
Wang, H., Yang, L., Liu, M., & Luo, J. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00464-3 · Cited by 162
“Several reviews have summarized metabolic reprogramming in cancer [246, 248, 249].”
BackgroundMorandi, A., Taddei, M. L., Chiarugi, P., & Giannoni, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00040 · Cited by 159
“These alterations identify a subset of patients characterized by poor prognosis (187, 188) and sometimes specific alterations of these mitochondrial enzymes are directly linked to EMT induction.”
BackgroundCorreia, C., Koshkin, A., Duarte, P., Hu, D., Carido, M., Sebastião, M. J., Gomes‐Alves, P., Elliott, D. A., Domian, I. J., Teixeira, A. P., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26504 · Cited by 139
“…activation of these regulatory pathways has been reported in highly proliferative cells and has been associated, apart from increased glycolysis, with enhanced lipogenesis, cell proliferation, and apoptosis (Cairns, Harris, & Mak, 2011; DeBerardinis & Chandel, 2016; Fritz & Fajas, 2010).”
BackgroundMitochondrial DNA: the overlooked oncogenome?
Gammage, P. A., & Frezza, C. (2019) · BMC Biology · doi:10.1186/s12915-019-0668-y · Cited by 148
Nitric Oxide: The Forgotten Child of Tumor Metabolism
Rizi, B. S., Achreja, A., & Nagrath, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.005 · Cited by 150
Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
Icard, P., Coquerel, A., Wu, Z., Gligorov, J., Fuks, D., Fournel, L., Lincet, H., & Simula, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126587 · Cited by 152
“Numerous cancer cells rely on aerobic glycolysis, a metabolism first identified by Otto Warburg [23], and extensively studied in recent years [33,34], in particular to understand how it can promote cancer cells’ aggressiveness and drug resistance [21,35].”
BackgroundA break in mitochondrial endosymbiosis as a basis for inflammatory diseases
Murphy, M. P., & O’Neill, L. A. J. (2024) · Nature · doi:10.1038/s41586-023-06866-z · Cited by 138
“In addition to individual metabolites signalling from mitochondria, there is also the well-established metabolic shift known as the Warburg effect 93 .”
Tumour microenvironment factors shaping the cancer metabolism landscape
Anastasiou, D. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.412 · Cited by 135
“Furthermore, the TCA cycle concomitantly produces reducing power in the form of NADH and FADH2 to generate the proton motive force across the inner mitochondrial membrane required for ATP synthesis (DeBerardinis and Chandel, 2016).”
BackgroundEnfield, K. S. S., Colliver, E., Lee, C., Magness, A., Moore, D. A., Sivakumar, M., Grigoriadis, K., Pich, O., Karasaki, T., Hobson, P. S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1380 · Cited by 151
“Nutrient-restrictive and hypoxic conditions can drive cancer cells to switch to substitute energy sources (27).”
Metabolic Fitness and Plasticity in Cancer Progression
McGuirk, S., Audet-Delage, Y., & St‐Pierre, J. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.11.009 · Cited by 142
Germline BAP1 mutations induce a Warburg effect
Bononi, A., Yang, H., Giorgi, C., Patergnani, S., Pellegrini, L., Su, M., Xie, G., Signorato, V., Pastorino, S., Morris, P., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.95 · Cited by 133
“transformation and in the surrounding stromal cells, creates an environment that promotes carcinogenesis and tumor growth.(20,46) Indeed, in all cell cultures from individuals carrying germline BAP1 mutations, we observed increased”
BackgroundCircular RNAs as biomarkers and therapeutic targets in cancer
Beilerli, A., Фанилевич, Г. И., Beylerli, O., Yang, G., Павлов, В. Н., Aliev, G., & Ahmad, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.026 · Cited by 147
Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., & Offidani, A. (2022) · Antioxidants · doi:10.3390/antiox11040612 · Cited by 132
“Indeed, the process of melanin biosynthesis requires oxidation reactions during which there is a production of O2•− and H2O2 that subjects melan cytes to oxidative stress [55,56].”
BackgroundReal-Time Imaging of Mitochondrial ATP Dynamics Reveals the Metabolic Setting of Single Cells
Depaoli, M. R., Karsten, F., Madreiter‐Sokolowski, C. T., Klec, C., Gottschalk, B., Bischof, H., Eroğlu, E., Waldeck‐Weiermair, M., Simmen, T., Graier, W. F., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.027 · Cited by 140
He, J., Qiu, Z., Fan, J., Xie, X., Sheng, Q., & Sui, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01891-4 · Cited by 160
“223 227 As a result of this disruption, normal cancer cells become damaged and transformed (Fig.”
BackgroundHypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Morotti, M., Bridges, E., Valli, A., Choudhry, H., Sheldon, H., Wigfield, S., Gray, N., Zois, C. E., Grimm, F., Jones, D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818521116 · Cited by 131
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
González‐Valdivieso, J., Girotti, A., Schneider, J., & Arias, F. J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120438 · Cited by 150
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130
Ochocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 130
“For example, enhanced glycolysis, first reported by Otto Warburg in the 1920s, provides a broad array of biosynthetic precursors required for the generation of amino acids, lipids, nucleotides, NADPH, and other biochemical intermediates (DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016).”
Augustin, R. C., Delgoffe, G. M., & Najjar, Y. G. (2020) · Cancers · doi:10.3390/cancers12123802 · Cited by 129
“An increase in glycolytic flux has certainly been demonstrated in many cancers, although glycolysis alone is not sufficient for energy production or tumor progression [83].”
BackgroundMetabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 197
“[2] For example, glutaminolysis produces α -KG that enters the TCA cycle and OXPHOS, and ultimately, generates more ATPs and biosynthetic precursors to support cancer growth.”
BackgroundThe Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
Giacomini, I., Ragazzi, E., Pasut, G., & Montopoli, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030937 · Cited by 150
“During the last decades, several studies demonstrated that the metabolic reprogramming of tumor cells, which is already known as a hallmark of cancer, has been playing an important role in the onset of chemotherapy resistance [12,13].”
BackgroundNuclear metabolism and the regulation of the epigenome
Boon, R., da Silveira, G. G., & Mostoslavsky, R. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00285-4 · Cited by 141
Zhang, B., Zeng, M., Wang, Y., Li, M., Wu, Y., Xu, R., Zhang, Q., Jia, J., Huang, Y., Zheng, X., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153818 · Cited by 134
Manipulating mitochondrial electron flow enhances tumor immunogenicity
Mangalhara, K. C., Varanasi, S. K., Johnson, M. A., Burns, M. J., Rojas, G. R., Esparza‐Moltó, P. B., Sainz, A. G., Tadepalle, N., Abbott, K. L., Mendiratta, G., et al. (2023) · Science · doi:10.1126/science.abq1053 · Cited by 137
Zhang, Z., Liu, R., Shuai, Y., Huang, Y., Jin, R., Wang, X., & Luo, J. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0637-9 · Cited by 142
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer
Tello‐Lafoz, M., Srpan, K., Sanchez, E. E., Hu, J. Y., Remšík, J., Romin, Y., Calò, A., Hoen, D. R., Bhanot, U. K., Morris, L. G. T., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.02.020 · Cited by 135
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
Zhao, F., An, R., Wang, L., Shan, J., & Wang, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.725284 · Cited by 140
Çağatay, T., & Chook, Y. M. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.01.006 · Cited by 126
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Stoykova, G. E., & Schlaepfer, I. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112626 · Cited by 134
“Cells distant from blood vessels have diminished access to nutrients and oxygen, and may switch to alternative forms of metabolism like oxidation of branched amino acids and fatty acids to support viability [46].”
BackgroundOshima, N., Ishida, R., Kishimoto, S., Beebe, K., Brender, J. R., Yamamoto, K., Urban, D., Rai, G., Johnson, M. S., Benavides, G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.039 · Cited by 125
“Recent advances in metabolomics, medicinal chemistry, and imaging techniques now make it possible to test the hypothesis that glycolysis and oxidative phosphorylation are functionally integrated in vivo and that both are essential to maintaining metabolic plasticity and tumor growth (DeBerardinis and Chandel, 2016; Ji…”
BackgroundMitochondrial Involvement in Migration, Invasion and Metastasis
Denisenko, T. V., Gorbunova, A. S., & Zhivotovsky, B. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00355 · Cited by 135
“Cancer cells change their metabolism in order to satisfy increasing of bioenergetic and biosynthetic demand and maintain tumor growth (DeBerardinis and Chandel, 2016).”
BackgroundWei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 148
The Pathophysiological Role of CoA
Czumaj, A., Szrok-Jurga, S., Hebanowska, A., Turyn, J., Świerczyński, J., Śledziński, T., & Stelmańska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239057 · Cited by 141
Gong, W. J., Xu, J., Wang, Y., Min, Q., Chen, X., Zhang, W., Chen, J., & Zhan, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00865-0 · Cited by 136
“DISCUSSION Previous studies have demonstrated that tumor cells under survival pressure will undergo energy metabolism reprogramming and plays an important role in this process.(31,32) In hypoxic microenvironment, accumulated HIF1α transcriptionally activates the expression of many genes which are involved in regulatin…”
BackgroundKetogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities
Talib, W. H., Mahmod, A. I., Kamal, A., Rashid, H. M., Alashqar, A. M. D., Khater, S. H., Jamal, D., & Waly, M. I. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020042 · Cited by 135
“Nevertheless, this alteration makes cancer cells dependent on a constant supply of nutrients and energy in addition to the studied deregulated glucose metabolism, which leads to the production of more amino acids and fatty acids, thus increasing fuel tumor cell growth [83,84].”
BackgroundGlucose Metabolism in Pancreatic Cancer
Liang, Y., Raj, P. S., Yao, W., & Ying, H. (2019) · Cancers · doi:10.3390/cancers11101460 · Cited by 145
“It has recently been shown that, compared to proliferating tumor cells, PDAC TICs are equipped with limited metabolic plasticity and exhibit decreased glycolysis activity accompanied with enhanced mitochondrial OXPHOS [99,100].”
BackgroundPeroxisome Metabolism in Cancer
Kim, J. (2020) · Cells · doi:10.3390/cells9071692 · Cited by 141
“Cancer cells tend to have increased rates of ROS production due to a combination of oncogenic lesions and the tumor microenvironment [1].”
BackgroundInfluentialLe, X., Mu, J., Peng, W., Tang, J., Xiang, Q., Tian, S., Feng, Y., He, S., Qiu, Z., Ren, G., et al. (2020) · Theranostics · doi:10.7150/thno.45631 · Cited by 128
“In the present study, we took multiple measures to estimate oxidative status alteration after ZDHHC1 overexpressing, and observed an increase in the levels of reactive species like H2O2, ROS and O2−, whereas no change in total antioxidants upon ZDHHC1 expression.”
BackgroundInfluentialMiller, B. A. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.03.002 · Cited by 135
Mitochondria as a target in cancer treatment
Liu, Y., & Shi, Y. (2020) · MedComm · doi:10.1002/mco2.16 · Cited by 130
Abdulbagi, M., Wang, L., Siddig, O., Di, B., & Li, B. (2021) · Biomolecules · doi:10.3390/biom11111716 · Cited by 135
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 120
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma
Riscal, R., Bull, C. J., Mesaros, C., Finan, J. M., Carens, M., Ho, E. S., Xu, J. P., Godfrey, J., Brennan, P., Johansson, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0211 · Cited by 120
Increased formate overflow is a hallmark of oxidative cancer
Meiser, J., Schuster, A., Pietzke, M., Vande Voorde, J., Athineos, D., Oizel, K., Burgos-Barragan, G., Wit, N., Dhayade, S., Morton, J. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03777-w · Cited by 118
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 137
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 156
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
Kosti, P., Maher, J. F., & Arnold, J. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01104 · Cited by 123
“Suppression in the TMe Tumor cells are highly metabolically active with increased glycolysis and glutaminolysis (101).”
BackgroundJézéquel, P., Kerdraon, O., Hondermarck, H., Guérin‐Charbonnel, C., Lasla, H., Gouraud, W., Canon, J.-L. R., Gombos, A., Dalenc, F., Delaloge, S., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1148-6 · Cited by 134
Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming
Pham, D., & Park, P. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02223-y · Cited by 134
“Tumor metabolic reprogramming is an important adaptive mechanism that provides cancer cells with metabolic plasticity to boost cell survival and infinite proliferation in a challenging tumor microenvironment [9].”
BackgroundStressed to death: Mitochondrial stress responses connect respiration and apoptosis in cancer
Winter, J. M., Yadav, T., & Rutter, J. P. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.07.012 · Cited by 126
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 117
“Conflicting reports exist about the impact of these metabolic alterations on the NADP/NADPH pool [86].”
BackgroundYuan, Q., Deng, D., Chen, P., Ren, J., Wei, T., Wu, Z., Zhang, B., Li, S., Yin, P., & Shang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951137 · Cited by 127
“In most tumours, high glycolysis is accompanied by upregulation of oxidative phosphorylation, ensuring the production of energy required for rapid tumour proliferation (50, 51).”
BackgroundFuhr, L., El‐Athman, R., Scrima, R., Cela, O., Carbone, A., Knoop, H., Li, Y., Hoffmann, K., Laukkanen, M. O., Corcione, F., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.07.002 · Cited by 130
“Metabolic alterations during tumorigenesis are a relevant factor to be considered for drug resistance [10].”
BackgroundInfluentialTargeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
Kutova, O. M., Guryev, E. L., Соколова, Е. А., Alzeibak, R., & Balalaeva, I. V. (2019) · Cancers · doi:10.3390/cancers11010068 · Cited by 125
Mitochondrial NADP+ is essential for proline biosynthesis during cell growth
Tran, D. H., Kesavan, R., Rion, H., Soflaee, M. H., Solmonson, A., Bezwada, D., Vu, H., Cai, F., Phillips, J. A., DeBerardinis, R. J., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00374-y · Cited by 124
Self-citationCharacterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux
Huang, Y., Mohanty, V., Dede, M., Tsai, K., Daher, M., Li, L., Rezvani, K., & Chen, K. (2023) · Nature Communications · doi:10.1038/s41467-023-40457-w · Cited by 141
FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis
Cordero, Á., Kanojia, D., Miska, J. M., Panek, W. K., Xiao, A., Han, Y., Bonamici, N. J., Zhou, W., Xiao, T., Wu, M., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0893-4 · Cited by 126
“The metastatic process has unique metabolic demands critical for the adaptation and survival of tumor cells when attempting to seed in a new environment [11].”
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
Sinkala, M., Mulder, N., & Martin, D. P. (2019) · Communications Biology · doi:10.1038/s42003-019-0666-1 · Cited by 123
The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
Jaworska, M., Szczudło, J., Pietrzyk, A., Shah, J., Trojan, S., Ostrowska, B., & Kocemba‐Pilarczyk, K. A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00504-1 · Cited by 141
“It is now a well-known fact that cancer cells have a greater predisposition for lactic acid formation even under adequate oxygen supply, referred to as aerobic glycolysis, which is rather unusual for normal cells [1].”
BackgroundMetabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
Schreiber, S., Hammers, C. M., Kaasch, A. J., Schraven, B. L., Dudeck, A., & Kahlfuß, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632581 · Cited by 127
“Tumors enable their rapid growth rate through glycolysis, which generates metabolic intermediates for the synthesis of amino acids, nucleotides, and fatty acids (105).”
BackgroundWang, C., Dong, Z., Hao, Y., Zhu, Y., Ni, J., Li, Q., Liu, B., Han, Y., Yang, Z., Wan, J., et al. (2021) · Advanced Materials · doi:10.1002/adma.202106520 · Cited by 137
Commander, R., Wei, C., Sharma, A., Mouw, J. K., Burton, L. J., Summerbell, E. R., Mahboubi, D., Peterson, R. J., Konen, J. M., Zhou, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15219-7 · Cited by 125
“Cancer cells exhibit altered glucose metabolism largely relying on glycolysis even in the presence of oxygen (Warburg effect) 45,46 ; however, the metabolism of invasive and metastatic cancer cells can differ from the proliferating bulk of the tumor cell population 47 – 49 .”
BackgroundLi, M., He, X., Guo, W., Yu, H., Zhang, S., Wang, N., Liu, G., Sa, R., Shen, X., Jiang, Y., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0086-7 · Cited by 120
Drury, J., Rychahou, P. G., He, D., Jafari, N., Wang, C., Lee, E. Y., Weiss, H. L., Evers, B. M., & Zaytseva, Y. Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01185 · Cited by 110
“Inhibition of FASN and CD36 in Combination Reduce Primary CRC Cell Proliferation in vitro Both de novo synthesized and exogenous FA play important roles in carcinogenesis (28, 39), To extend our findings that FASN inhibition upregulates the expression of CD36 and to further test whether inhibition of CD36 can improve…”
BackgroundMethodHumanized mouse models of immunological diseases and precision medicine
Shultz, L. D., Keck, J., Burzenski, L., Jangalwe, S., Vaidya, S., Greiner, D. L., & Brehm, M. A. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09796-2 · Cited by 109
Yu, T., Ma, D., Liu, Y., Xiao, Y., Gong, Y., Jiang, Y., Shao, Z.-M., Hu, X., & Di, G. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.003 · Cited by 127
Lin, K. H., Xie, A., Rutter, J. C., Ahn, Y.-R., Lloyd-Cowden, J. M., Nichols, A. G., Soderquist, R. S., Koves, T. R., Muoio, D. M., MacIver, N. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.011 · Cited by 109
Immunometabolism and HIV-1 pathogenesis: food for thought
Sáez‐Cirión, A., & Sereti, I. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0381-7 · Cited by 126
Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How
Bröer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176156 · Cited by 136
“Synergy could potentially be generated by blocking NADPH-generating pathways such as the pentose–phosphate pathway, malic enzyme [87,88], or isocitrate dehydrogenase [89].”
BackgroundWang, C., Chiao, C.-C., Phan, N. N., Li, C.-Y., Sun, Z., Jiang, J., Hung, J., Chen, Y., Yen, M., Weng, T.-Y., et al. (2020) · PubMed Central · Cited by 124
Mukund, K., Siuliukina, N., Ramamoorthy, S. L., & Subramaniam, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-06784-7 · Cited by 130
Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms
Laussel, C., & Léon, S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114213 · Cited by 117
Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Darwiche, N. (2020) · PubMed Central · Cited by 163
Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism
Eriksson, M., Ambroise, G., Ouchida, A. T., Lima Queiroz, A., Smith, D., Gimenez-Cassina, A., Iwanicki, M. P., Muller, P. A., Norberg, E., & Vakifahmetoglu-Norberg, H. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00328-17 · Cited by 106
Metabolic recoding of epigenetics in cancer
Wang, Y., & Lei, Q. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0302-3 · Cited by 123
Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable Prodrug
Sharma, A. K., Lee, M. G., Shi, H., Won, M., Arambula, J. F., Sessler, J. L., Lee, J. Y., Chi, S., & Kim, J. S. (2018) · Chem · doi:10.1016/j.chempr.2018.08.002 · Cited by 108
Condelli, V., Crispo, F., Pietrafesa, M., Lettini, G., Matassa, D. S., Esposito, F., Landriscina, M., & Maddalena, F. (2019) · Cells · doi:10.3390/cells8060532 · Cited by 104
“Cancer cells are able to reprogram their metabolism so as to acquire and maintain malignant properties in order to adapt rapidly and survive in ever-changing environments [52,56,121,122].”
BackgroundIdentification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
Chen, Q., Li, F., Gao, Y., Xu, G., Liang, L., & Xu, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01210 · Cited by 116
“Energy metabolism has long been a hallmark of cancer cells, enabling tumor cells to produce adenosine triphosphate (ATP) to maintain the reduction-oxidation balance and macromolecular biosynthesis processes required for cell growth, proliferation, and migration (3, 4).”
BackgroundMethodAltered propionate metabolism contributes to tumour progression and aggressiveness
Gomes, A. P., Ilter, D., Low, V., Drapela, S., Schild, T., Mullarky, E., Han, J., Elia, I., Broekaert, D., Rosenzweig, A., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00553-5 · Cited by 104
Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy
Guerra, Â. R., Duarte, M. F., & Duarte, I. F. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04104 · Cited by 109
Chen, J., Zou, L., Lu, G. X., Grinchuk, O. V., Fang, L., Ong, D. S. T., Taneja, R., Ong, C. N., & Shen, H. (2022) · Cell Discovery · doi:10.1038/s41421-022-00406-1 · Cited by 117
Cantor, J. R. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.009 · Cited by 100
“Across diverse cell types that include human cancers, stem cells, and components of the immune system, cultured cells are used to examine various metabolic characteristics and points of intersection between metabolism and other processes [11-13].”
BackgroundA Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism
Lee, J., & Padilla, J. (2021) · Cells · doi:10.3390/cells10030634 · Cited by 109
“Aerobic glycolysis in the presence of oxygen represents convergent cancer metabolic phenotypes, providing a diagnostic foundation for tumor detection [1,2,4,42], and this aerobic glycolysis is regulated by BACH1 in lung cancer cells [11].”
BackgroundNakajima, Y., Chamoto, K., Oura, T., & Honjo, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103730118 · Cited by 117
Lunetti, P., Di Giacomo, M., Vergara, D., De Domenico, S., Maffia, M., Zara, V., Capobianco, L., & Ferramosca, A. (2019) · The FEBS Journal · doi:10.1111/febs.14756 · Cited by 102
Could ketogenic diet “starve” cancer? Emerging evidence
Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1847030 · Cited by 102
“The rapid growth of CCs requires very high functional mitochondria to support the increased energy expenditure by the cell; thus, oncogenic lesions are likely to modify the metabolism used by mitochondria to sustain tumor growth (De Berardinis and Chandel 2016).”
BackgroundQiu, P., Zhou, Y., Oyang, L., Wu, N., Tang, Y., Su, M., Luo, X., Wang, Y., Sheng, X., Ma, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.010 · Cited by 121
Dysregulated FOXM1 signaling in the regulation of cancer stem cells
Sher, G., Masoodi, T., Patil, K., Akhtar, S., Kuttikrishnan, S., Ahmad, A., & Shahab Uddin, M. S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.009 · Cited by 115
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk
Moore, S. C., Playdon, M. C., Sampson, J. N., Hoover, R. N., Trabert, B. L., Matthews, C. E., & Ziegler, R. G. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx244 · Cited by 119
“Biologically, degradation of BCAAs through alternative pathways has been postulated to promote tumor growth by providing nutritive building blocks needed for mitosis (49,50), and by anaplerotically replenishing the TCA cycle (50), thus helping cancer cells to meet energetic demands.”
Epigenetics and Metabolism in Health and Disease
Tzika, E., Dreker, T., & Imhof, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00361 · Cited by 116
“Dysregulated metabolism is a hallmark of cancer (DeBerardinis and Chandel, 2016; Vander Heiden and DeBerardinis, 2017).”
BackgroundTumor-on-a-chip: a microfluidic model to study cell response to environmental gradients
Ayuso, J. M., Virumbrales-Munoz, M., McMinn, P. H., Rehman, S., Gomez, I., Karim, M. R., Trusttchel, R., Wisinski, K. B., Beebe, D. J., & Skala, M. C. (2019) · Lab on a Chip · doi:10.1039/c9lc00270g · Cited by 100
In Situ DESI-MSI Lipidomic Profiles of Breast Cancer Molecular Subtypes and Precursor Lesions
Santoro, A. L., Drummond, R. D., da Silva, I. T., Ferreira, S. S., Juliano, L., Vendramini, P. H., Lemos, M. B. D. C., Eberlin, M. N., & de Andrade, V. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-18-3574 · Cited by 109
Targeting glutamine metabolism slows soft tissue sarcoma growth
Lee, P., Malik, D. M., Perkons, N. R., Huangyang, P., Khare, S., Rhoades, S. D., Gong, Y.-Y., Burrows, M., Finan, J. M., Nissim, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14374-1 · Cited by 109
Tyrosine Kinase Receptors in Oncology
Esteban-Villarrubia, J., Castillo, J. J. S., Pozas, J., Román, M. S., Orejana, I., Torres-Jiménez, J., Carrato, A., Alonso‐Gordoa, T., & Molina‐Cerrillo, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228529 · Cited by 118
Chen, C., Yu, H., Han, F., Lai, X., Ye, K., Lei, S., Mai, M., Lai, M., & Zhang, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01511-1 · Cited by 113
“4E) and EMT phenotype (Fig.”
BackgroundInfluentialMetabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
Parida, P. K., Marquez-Palencia, M., Nair, V. R., Kaushik, A., Kim, K., Sudderth, J., Quesada-Diaz, E., Cajigas, Á., Vemireddy, V., Ericsson, P. I. G., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.001 · Cited by 107
Self-citationVerma, S., Budhu, S., Serganova, I. S., Dong, L., Mangarin, L. M. B., Khan, J. F., Bah, M. A., Assouvie, A., Marouf, Y., Schulze, I., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177606 · Cited by 113
Keshet, R., Lee, J. S., Adler, L. N., Iraqi, M., Ariav, Y., Lim, L. Q. J., Lerner, S., Rabinovich, S., Oren, R., Katzir, R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0106-7 · Cited by 109
The lactate sensor GPR81 regulates glycolysis and tumor growth of breast cancer
Ishihara, S., Hata, K., Hirose, K., Okui, T., Toyosawa, S., Uzawa, N., Nishimura, R., & Yoneda, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-10143-w · Cited by 104
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.